Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Treat pattern hair loss with finasteride and topical minoxidil.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Long COVID patients have more health issues than non-infected people.

Finasteride does not prevent bladder cancer.

Alternative treatments show promise for hair growth beyond traditional methods.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Minoxidil works well as a high permeability reference drug for biopharmaceutics classification.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Dupilumab for skin problems might reactivate hair loss in some patients.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.